Home/Aptose Biosciences/William G. Rice, Ph.D.
WG

William G. Rice, Ph.D.

Chairman of the Board, President & Chief Executive Officer

Aptose Biosciences

Aptose Biosciences Pipeline

DrugIndicationPhase
Tuspetinib (HM43239)Relapsed/Refractory AMLPhase 1/2
Luxeptinib (CG-806)Relapsed/Refractory B-cell malignancies (CLL, NHL)Phase 1a/b